Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Non-Current Deffered Revenue (2022 - 2023)

Envoy Medical's Non-Current Deffered Revenue history spans 2 years, with the latest figure at $10.4 million for Q2 2023.

  • For Q2 2023, Non-Current Deffered Revenue fell 30.0% year-over-year to $10.4 million; the TTM value through Jun 2023 reached $10.4 million, down 30.0%, while the annual FY2022 figure was $10.4 million, N/A changed from the prior year.
  • Non-Current Deffered Revenue for Q2 2023 was $10.4 million at Envoy Medical, roughly flat from $10.4 million in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $14.9 million in Q1 2022 and bottomed at $10.4 million in Q3 2022.